Mirae Asset Global Investments Co., Ltd. Erasca, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Erasca, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 10,218 shares of ERAS stock, worth $31,777. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,218
Previous 7,758
31.71%
Holding current value
$31,777
Previous $18,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ERAS
# of Institutions
135Shares Held
206MCall Options Held
3.1KPut Options Held
142K-
Vr Adviser, LLC New York, NY16.2MShares$50.4 Million4.2% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA16.2MShares$50.4 Million2.26% of portfolio
-
Suvretta Capital Management, LLC New York, NY13.8MShares$42.8 Million1.36% of portfolio
-
Arch Venture Management, LLC Chicago, IL11.1MShares$34.4 Million15.29% of portfolio
-
Black Rock Inc. New York, NY10.6MShares$33 Million0.0% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $380M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...